Lexicon Pharmaceuticals (LXRX)

Add to Watchlists
Create an Alert
1.625 +0.07  +4.84% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
LXRX Price Chart
View All Events

LXRX Events

Date Type Description
Feb 28 Misc Lexicon Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
Feb 28 Earnings Lexicon Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.06.
Nov 12 Misc Lexicon to Report Third Quarter Financial Results Conference Call
Nov 12 Earnings Lexicon to Report Third Quarter Financial Results on November 12, 2013. Estimate: -0.06.
Jul 30 Misc Lexicon to Report Second Quarter Financial Results on July 30, 2013
Jul 30 Earnings Lexicon to Report Second Quarter Financial Results on July 30, 2013. Estimate: -0.05.
May 10 Misc Lexicon Pharmaceuticals, Inc. 2013 First Quarter Earnings Conference Call
May 10 Earnings Lexicon Pharmaceuticals, Inc. 2013 First Quarter Earnings Results. Estimate: -0.05.
View All Performance Charts

LXRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Lexicon Pharmaceuticals is down 25.12% over the last year vs S&P 500 Total Return up 20.96%, Regeneron Pharmaceuticals up 37.25%, and Celgene up 15.62%.

Get Quote for

PDF Report for LXRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download LXRX Pro Report PDF
Advertisement

Portfolio Strategies Featuring LXRX

Did Lexicon Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

LXRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Texas
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Lexicon Pharmaceuticals, Inc., operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease.

Recent Quotes

Symbol Price Chg Chg % Market Cap
LXRX 1.625 +0.07 +4.84% 834.91M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.